Patents by Inventor Steven RUSCHE

Steven RUSCHE has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Authenticating, establishing and tracking eligibility of a patient to purchase an over-the-counter drug
    Patent number: 12293817
    Abstract: A method is provided for authenticating, and establishing and tracking eligibility of a patient to purchase an over-the-counter (OTC) drug from a retailer, the patient using a client device or terminal and the retailer having a server. The server is configured to redirect the client device or terminal to a backend platform to authenticate the patient, access a storage to search for any information that indicates the patient is ineligible to purchase the OTC drug; and without any information that indicates the patient is ineligible, administer a questionnaire to the patient to assess the eligibility for the OTC drug. And the backend platform redirects the client device or terminal back to the server to complete the online sale of the OTC drug to the patient when the patient is eligible, or cancel the online sale of the OTC drug to the patient when the patient is ineligible.
    Type: Grant
    Filed: February 5, 2024
    Date of Patent: May 6, 2025
    Assignee: Bayer HealthCare LLC
    Inventors: Rama Penta, Jeffrey Brittain, William Hanisak, Audrey Belkin, Steven Rusche
  • AUTHENTICATING, ESTABLISHING AND TRACKING ELIGIBILITY OF A PATIENT TO PURCHASE AN OVER-THE-COUNTER DRUG
    Publication number: 20240177820
    Abstract: A method is provided for authenticating, and establishing and tracking eligibility of a patient to purchase an over-the-counter (OTC) drug from a retailer, the patient using a client device or terminal and the retailer having a server. The server is configured to redirect the client device or terminal to a backend platform to authenticate the patient, access a storage to search for any information that indicates the patient is ineligible to purchase the OTC drug; and without any information that indicates the patient is ineligible, administer a questionnaire to the patient to assess the eligibility for the OTC drug. And the backend platform redirects the client device or terminal back to the server to complete the online sale of the OTC drug to the patient when the patient is eligible, or cancel the online sale of the OTC drug to the patient when the patient is ineligible.
    Type: Application
    Filed: February 5, 2024
    Publication date: May 30, 2024
    Applicant: Bayer HealthCare LLC
    Inventors: Rama PENTA, Jeffrey BRITTAIN, William HANISAK, Audrey BELKIN, Steven RUSCHE
  • Authenticating, establishing and tracking eligibility of a patient to purchase an over-the-counter drug
    Patent number: 11923060
    Abstract: A method is provided for authenticating, and establishing and tracking eligibility of a patient to purchase an over-the-counter (OTC) drug from a retailer, the patient using a client device or terminal and the retailer having a server. The server is configured to redirect the client device or terminal to a backend platform to authenticate the patient, access a storage to search for any information that indicates the patient is ineligible to purchase the OTC drug; and without any information that indicates the patient is ineligible, administer a questionnaire to the patient to assess the eligibility for the OTC drug. And the backend platform redirects the client device or terminal back to the server to complete the online sale of the OTC drug to the patient when the patient is eligible, or cancel the online sale of the OTC drug to the patient when the patient is ineligible.
    Type: Grant
    Filed: March 9, 2023
    Date of Patent: March 5, 2024
    Assignee: Bayer HealthCare LLC
    Inventors: Rama Penta, Jeffrey Brittain, William Hanisak, Audrey Belkin, Steven Rusche
  • AUTHENTICATING, ESTABLISHING AND TRACKING ELIGIBILITY OF A PATIENT TO PURCHASE AN OVER-THE-COUNTER DRUG
    Publication number: 20230245744
    Abstract: A method is provided for authenticating, and establishing and tracking eligibility of a patient to purchase an over-the-counter (OTC) drug from a retailer, the patient using a client device or terminal and the retailer having a server. The server is configured to redirect the client device or terminal to a backend platform to authenticate the patient, access a storage to search for any information that indicates the patient is ineligible to purchase the OTC drug; and without any information that indicates the patient is ineligible, administer a questionnaire to the patient to assess the eligibility for the OTC drug. And the backend platform redirects the client device or terminal back to the server to complete the online sale of the OTC drug to the patient when the patient is eligible, or cancel the online sale of the OTC drug to the patient when the patient is ineligible.
    Type: Application
    Filed: March 9, 2023
    Publication date: August 3, 2023
    Applicant: Bayer HealthCare LLC
    Inventors: Rama PENTA, Jeffrey BRITTAIN, William HANISAK, Audrey BELKIN, Steven RUSCHE
  • Authenticating, establishing and tracking eligibility of a patient to purchase an over-the-counter drug
    Patent number: 11636935
    Abstract: A method is provided for authenticating, and establishing and tracking eligibility of a patient to purchase an over-the-counter (OTC) drug from a retailer, the patient using a client device or terminal and the retailer having a server. The server is 5 configured to redirect the client device or terminal to a backend platform to authenticate the patient, access a storage to search for any information that indicates the patient is ineligible to purchase the OTC drug; and without any information that indicates the patient is ineligible, administer a questionnaire to the patient to assess the eligibility for the OTC drug. And the backend platform redirects the client device 10 or terminal back to the server to complete the online sale of the OTC drug to the patient when the patient is eligible, or cancel the online sale of the OTC drug to the patient when the patient is ineligible.
    Type: Grant
    Filed: February 28, 2019
    Date of Patent: April 25, 2023
    Assignee: Bayer Healthcare LLC
    Inventors: Rama Penta, Jeffrey Brittain, William Hanisak, Audrey Belkin, Steven Rusche
  • AUTHENTICATING, ESTABLISHING AND TRACKING ELIGIBILITY OF A PATIENT TO PURCHASE AN OVER-THE-COUNTER DRUG
    Publication number: 20210005301
    Abstract: A method is provided for authenticating, and establishing and tracking eligibility of a patient to purchase an over-the-counter (OTC) dmg from a retailer, the patient using a client device or terminal and the retailer having a server. The server is 5 configured to redirect the client device or terminal to a backend platform to authenticate the patient, access a storage to search for any information that indicates the patient is ineligible to purchase the OTC drug; and without any information that indicates the patient is ineligible, administer a questionnaire to the patient to assess the eligibility for the OTC drug. And the backend platform redirects the client device 10 or terminal back to the server to complete the online sale of the OTC drug to the patient when the patient is eligible, or cancel the online sale of the OTC dmg to the patient when the patient is ineligible.
    Type: Application
    Filed: February 28, 2019
    Publication date: January 7, 2021
    Inventors: Rama PENTA, Jeffrey BRITTAIN, William HANISAK, Audrey BELKIN, Steven RUSCHE